Biomerica Receives Notice of Allowance from Canadian Patent

Studies show that 13-20% of Canadians suffer from IBS at any given time1. The lifetime risk for a Canadian to develop IBS is 30%1. IRVINE, Calif., Nov. ...

Related Keywords

Mexico ,Japan ,United States ,Canada ,Japanese ,Mexican ,America ,Canadians ,Canadian ,John Nesbett Jennifer Belodeau ,Biomerica Infoods ,Zack Irani ,Canadian Patent Office ,Company Infoods ,Gastrointestinal Society Of Canada ,Biomerica Inc ,Nasdaq ,Irritable Bowel Syndrome ,Chief Executive Officer ,Gastroesophageal Reflux Disease ,Functional Dyspepsia ,Inflammatory Bowel ,Private Securities Litigation Reform Act ,Nasdaq Bmra ,Biomerica ,Nc ,Bs Therapy ,Inflammatory Bowel Disease ,Clinical Trial ,